iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cardiometabolic and obesity space. The company's technology platforms include EngageTx that provides a panel of optimized CD3 antibodies that can be paired with...
18 insider purchases on record · latest filing 2026-03-27.
Insiders have also filed 88 sale transactions at IBIO.